HOME >> MEDICINE >> NEWS
Prediction markets accurately forecast influenza activity

Influenza experts have borrowed a page from economists, creating a futures market for influenza activity that predicted outbreaks two to four weeks in advance. The influenza prediction market is presented in the Jan. 15 issue of Clinical Infectious Diseases.

Influenza outbreaks happen every year, but when they hit and how severe they are varies. Knowing the timing and severity of an outbreak would give public health workers time to prepare and to notify the public to get their influenza vaccinations.

In a prediction market, people with information about a future event buy and sell shares based on what they believe the likelihood of that event will be. For instance, if a health care worker started seeing more cases of influenza in her clinic, she would buy shares representing increased levels of flu in the coming weeks and sell shares representing decreased activity. The prices at which these shares trade reflect the group's consensus on the future event. Prediction markets have accurately forecast the outcomes of a wide range of future events including presidential elections, Oscar nominees, and the Federal Reserve's decisions about interest rates.

"For decades, farmers have used futures markets to make decisions about what crops to plant," says Philip Polgreen, MD, of the University of Iowa. "We're just borrowing that technology to help people in public health and health care make decisions about the future."

"Many health care workers possess current information that could be used to predict future infectious disease trends," explains Dr. Polgreen. But there is no mechanism to gather that data and digest it quickly enough to make it useful. "Prediction markets provide a way to collect and analyze information in real time in an easy-to-interpret graphical format," Dr. Polgreen says.

Dr. Polgreen and his collaborators set up a "flu market" for the 2004-05 influenza season in the state of Iowa. Sixty-one health c
'"/>

Contact: Steve Baragona
sbaragona@idsociety.org
703-299-0412
Infectious Diseases Society of America
21-Dec-2006


Page: 1 2

Related medicine news :

1. Simple system accurately predicts weight-loss surgery risk
2. Prematurity more accurately predicted by advances in proteomic technology
3. Workers compensation ratings dont accurately predict disabilities
4. Hospital performance measures may not accurately reflect quality of care or predict patient outcomes
5. New GreeneChip identifies multiple pathogens rapidly and accurately
6. GreeneChip -- New diagnostic tool that rapidly and accurately identifies multiple pathogens
7. Inexpensive test detects H5N1 infections quickly and accurately
8. High-resolution CT accurately diagnoses shin splints
9. Magic formula accurately predicts fracture risk in osteoporotic women
10. Concussion in athletes: Can they accurately evaluate their own condition?
11. MRI more accurately determines cancer spread into breast ducts

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Prediction markets accurately forecast influenza activity

(Date:4/17/2014)... signs of chronic inflammation in non-cancerous prostate tissue may ... cancer than those with no inflammation, according to results ... Johns Hopkins Kimmel Cancer Center. , The link between ... with so-called high-grade prostate cancer those with a ... presence of the most aggressive and rapidly growing prostate ...
(Date:4/17/2014)... a study published today in PLOS Pathogens , ... malaria is common can mount an immune response to ... avoid repeated bouts of high fever and illness and ... bloodstream. The findings may help researchers develop future interventions ... malaria parasite. , Each year, approximately 200 million cases ...
(Date:4/17/2014)... In a review published in the April issue of ... The Feinstein Institute for Medical Research, says it,s time ... approach to treating sepsis, which kills millions ... Sepsis occurs when molecules released into the bloodstream to ... body. Inflammation is necessary for maintaining good health ...
(Date:4/17/2014)... Doctors who treat patients with a severe and ... an agonizing treatment decision. , The drug sirolimus ... relieve shortness of breath. But some patients eventually ... potentially fatal complications following transplantation. , "It,s a ... director of Loyola University Medical Center,s LAM Clinic ...
(Date:4/17/2014)... By discovering a new mechanism that allows blood to ... UC Irvine and the Salk Institute have opened the ... stroke-induced brain damage. , A complex and devastating neurological ... primary reason for disability in the U.S. The blood-brain ... blood-borne material into the brain, causing the permanent deficits ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Study IDs new cause of brain bleeding immediately after stroke 2
(Date:1/15/2014)...  Zafgen, Inc., a leading biopharmaceutical company dedicated to ... today announced initial results from its Phase 2a ... aminopeptidase 2 (MetAP2), in patients with Prader-Willi syndrome ... results showed improvements in body weight, hunger-related behaviors, ...
(Date:1/14/2014)... 2014 HeartWare International, Inc . (NASDAQ: ... miniaturized circulatory support technologies that are revolutionizing the treatment ... revenues for the fourth quarter of 2013 will be ... approximately $208 million. "Our full-year revenue growth ...
(Date:1/14/2014)... 14, 2014 InformEx, North America,s ... chemistry, will hold the 30 th edition of its ... Convention Center from January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ... pharmaceutical, fine chemical and specialty chemical companies will take part ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Cached News: